share_log

沃森生物(300142.SZ):近期正在开展婴幼儿人群加强免疫阶段数据的统计分析

Walvax biotechnology (300142.SZ): Recently conducting statistical analysis on the booster immunization stage data for infants and young children.

Gelonghui Finance ·  Nov 20, 2024 12:06

On November 20, Gelonghui reported that walvax biotechnology (300142.SZ) stated on the investor interaction platform that the ACYW135 group meningococcal polysaccharide conjugate vaccine developed by the company is currently in the III phase of clinical trials, and recent statistical analysis of the booster immunization phase data for infants and young children is being conducted.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment